Evidence map›Paper›PMID 33507996›Full record

ArticlePLoS neglected tropical diseases2021

Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure.

Megan Halbrook, Adva Gadoth, Anupama Shankar, HaoQiang Zheng, Ellsworth M Campbell, Nicole A Hoff, Jean-Jacques Muyembe, Emile Okitolonda Wemakoy, Anne W Rimoin, William M Switzer

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. A role for an HTLV-1 vaccine?Frontiers in immunology · 2022
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Megan HalbrookUniversity of California Los Angeles, Fielding School of Public Health, Los Angeles, California, United States of America.ORCID 0000-0002-3892-2655
Adva GadothUniversity of California Los Angeles, Fielding School of Public Health, Los Angeles, California, United States of America.ORCID 0000-0002-3217-2435
Anupama ShankarLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
HaoQiang ZhengLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Ellsworth M CampbellLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0002-9535-4420
Nicole A HoffUniversity of California Los Angeles, Fielding School of Public Health, Los Angeles, California, United States of America.ORCID 0000-0002-1770-6304
Jean-Jacques MuyembeInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Emile Okitolonda WemakoyKinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Anne W RimoinUniversity of California Los Angeles, Fielding School of Public Health, Los Angeles, California, United States of America.ORCID 0000-0002-0662-9067
William M SwitzerLaboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-4591-8731
Centers for Disease Control and Prevention · USUniversity of California, Los Angeles · USNational Institute of Biomedical Research · CDUniversity of Kinshasa · CD

Funding

Emergence of Human Monkeypox in Central AfricaK01AI074810 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RIMOIN, ANNE WALSH · 2008 to 2012
$609k
NIAID NIH HHS K01 AI074810
6 · The paper itself

Abstract

The Democratic Republic of the Congo (DRC) has a history of nonhuman primate (NHP) consumption and exposure to simian retroviruses yet little is known about the extent of zoonotic simian retroviral infections in DRC. We examined the prevalence of human T-lymphotropic viruses (HTLV), a retrovirus group of simian origin, in a large population of persons with frequent NHP exposures and a history of simian foamy virus infection. We screened plasma from 3,051 persons living in rural villages in central DRC using HTLV EIA and western blot (WB). PCR amplification of HTLV tax and LTR sequences from buffy coat DNA was used to confirm infection and to measure proviral loads (pVLs). We used phylogenetic analyses of LTR sequences to infer evolutionary histories and potential transmission clusters. Questionnaire data was analyzed in conjunction with serological and molecular data. A relatively high proportion of the study population (5.4%, n = 165) were WB seropositive: 128 HTLV-1-like, 3 HTLV-2-like, and 34 HTLV-positive but untypeable profiles. 85 persons had HTLV indeterminate WB profiles. HTLV seroreactivity was higher in females, wives, heads of households, and increased with age. HTLV-1 LTR sequences from 109 persons clustered strongly with HTLV-1 and STLV-1 subtype B from humans and simians from DRC, with most sequences more closely related to STLV-1 from Allenopithecus nigroviridis (Allen's swamp monkey). While 18 potential transmission clusters were identified, most were in different households, villages, and health zones. Three HTLV-1-infected persons were co-infected with simian foamy virus. The mean and median percentage of HTLV-1 pVLs were 5.72% and 1.53%, respectively, but were not associated with age, NHP exposure, village, or gender. We document high HTLV prevalence in DRC likely originating from STLV-1. We demonstrate regional spread of HTLV-1 in DRC with pVLs reported to be associated with HTLV disease, supporting local and national public health measures to prevent spread and morbidity.

Indexed as

AdolescentAnimalsAnimals, WildChildDemocratic Republic of the CongoFamily CharacteristicsFemaleHTLV-I InfectionsHumansHuman T-lymphotropic virus 1Human T-lymphotropic virus 2Monkey DiseasesPhylogenyPrimatesProvirusesPublic Health

Identifiers

PMID33507996
PMCPMC7872225
OpenAlexW3125863062

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.